Sabay, Maudina T.
HRN: 23-65-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
CEFTRIAXONE 1G (VIAL)
09/04/2023
09/10/2023
IV
2g
Od
Pleural Effusion, R
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes